data integration Tempus Takes on Precision Neuropsychiatry With New Research Dataset Premium In its new N+ program, Tempus will build a multimodal dataset from exome sequencing and patient records to inform drug discovery and mental health treatment. BC Platforms, Euformatics, Oncompass to Develop Oncology NGS Workflows for European Hospitals The companies have won a partially EU-funded contract from a coalition of seven hospitals to integrate, standardize, and analyze NGS data to inform clinical decision support. Qiagen Expands Into Data Scientist Market With 'Biomedical Knowledge Base' Product Premium The company said that this is the first of a planned series of products for data scientists based on Qiagen Data Insights datasets. SAS, BC Platforms Partnership Expected to Open New Markets, Improve Data Integration Premium Data analytics giant SAS picks up where BC Platforms leaves off and is able to bring in other bioinformatics applications under its user interface. Insightful Science Takes Dotmatics Name, Eyes Integrated R&D Workflows Premium The newly rebranded Dotmatics, which has been growing through a series of acquisitions, is touting its data integration capabilities to support drug discovery. Apr 25, 2022 Zephyr AI Looks to Serve Drug Discovery, Value-Based Care Markets Premium Apr 21, 2022 Consensus Builds for Real-World Evidence to Support Multi-Cancer Screening Tests Premium Apr 13, 2022 Meditech Installs EHR Genomics Add-on at Health Systems in Pursuit of Precision Medicine Premium Apr 6, 2022 2bPrecise, Now Part of AccessDx, Wants to Bridge Genomic Lab Results, Clinical Decision Support Premium Mar 30, 2022 Zephyr AI Closes $18.5M Seed Round Mar 25, 2022 Nalagenetics Closes $12.6M Series A Funding Round Mar 14, 2022 DNAnexus Looks to Beef Up Data Science, AI, 'Digital Diagnostics' After $200M Funding Round Premium Feb 25, 2022 LifeOmic Evolving Into Precision Medicine, Corporate Wellness Company Premium Feb 11, 2022 Seqster Expands Customer Base to CROs, Registries as it Eyes Wider Acceptance Premium Feb 3, 2022 Seqster Partners With United BioSource to Enable Decentralized Clinical Trials Jan 4, 2022 Genomenon, OmniTier to Integrate Genome Analysis Technologies Dec 14, 2021 BostonGene Partners with NEC to Offer Tumor Portrait Tests Internationally Dec 10, 2021 GE Healthcare Precision Oncology Pacts Focus on Cracking Data Silos, Improving Patient Outcomes Premium Dec 1, 2021 Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests Nov 10, 2021 Sophia Genetics Q3 Revenues Increase 44 Percent Oct 29, 2021 AMP Calls for Standards for Reporting Genetic, Genomic Test Data in EHRs Premium Sep 29, 2021 Europe's 1+Million Genomes Initiative Pressing Forward Despite Legal Obstacles Premium Aug 25, 2021 AccessDx Acquires 2bPrecise From Allscripts Aug 5, 2021 NYU Langone Health, Philips Integrate Informatics for FDA-Cleared Cancer Sequencing Panel Premium Jul 12, 2021 Standard Molecular Looks to Streamline NGS Test Ordering for Community Oncologists Premium Load More Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.